Skip to main content
Oxurion NV logo

Oxurion NV — Investor Relations & Filings

Ticker · OXUR ISIN · BE0974487192 LEI · 549300VWY8KVDFKLDM59 BR Professional, scientific and technical activities
Filings indexed 1,031 across all filing types
Latest filing 2026-05-05 Major Shareholding Noti…
Country BE Belgium
Listing BR OXUR

About Oxurion NV

https://oxurion.com/

Oxurion NV is a company focused on acquiring majority stakes in European pharmaceutical subcontractors. Its strategy is to build an integrated group of contract service providers to support healthcare stakeholders. A key asset in its portfolio is a majority stake in Axiodis CRO, a contract research organization specializing in biometrics. This investment-based business model represents a strategic pivot from the company's former focus on the internal research and development of therapies for retinal diseases such as Geographic Atrophy (GA) and Age-related Macular Degeneration (AMD).

Recent filings

Filing Released Lang Actions
OXUR-Transparency-Notification-EN-20260505.pdf
Major Shareholding Notification Classification · 95% confidence The document is a press release announcing a transparency notification received by Oxurion NV from Atlas Special Opportunities II LLC. It details the crossing below the 10% ownership threshold in voting securities, pursuant to Belgian Transparency legislation. The document includes specific shareholding numbers, dates, and legal references related to disclosure of major holdings. There is no financial performance data, earnings information, or management discussion. The content is focused on notifying a change in major shareholding levels, which fits the definition of a Major Shareholding Notification (MRQ). The document length is sufficient and contains detailed data about shareholding changes, not just a brief mention or a report publication announcement. Therefore, the correct classification is MRQ with high confidence.
2026-05-05 English
OXUR-Transparency-Notification-NL-20260505.pdf
Major Shareholding Notification Classification · 100% confidence The document is a transparency notification regarding a change in shareholding by Atlas Special Opportunities II LLC in Oxurion NV. It details the disposal of voting securities and the crossing below the 10% ownership threshold. The document includes specific dates, share counts, and percentages related to the shareholding changes. It references Belgian transparency legislation and provides detailed information consistent with a major shareholding notification. There is no indication of financial statements, management discussion, or other report types. The document is not an announcement of a report publication but the actual notification of shareholding changes. Therefore, the appropriate classification is Major Shareholding Notification (MRQ). The document length (8690 characters) supports it being a full notification rather than a brief announcement.
2026-05-05 Dutch
Oxurion - Special report BoD 7-228_exe.pdf
Board/Management Information Classification · 95% confidence The document is a special report of the board of directors pursuant to Article 7:228 of the Belgian Companies and Associations Code. It discusses the company's financial condition as of December 31, 2025, including detailed balance sheet and income statement data. The report addresses the company's net assets falling below one-fourth of its capital, the application of the alarm bell procedure, and proposed measures to safeguard the company's continuity, including amendments to a funding program. The document is a detailed board report on financial distress and remedial actions, not a full annual report or audit report. It is not a simple announcement or certification but a substantive report by the board on financial condition and continuity measures. This fits the category of Board/Management Information (MANG), which includes announcements of board decisions and management information related to company governance and financial condition. The length and detail confirm it is not a brief announcement or regulatory filing. Therefore, the appropriate classification is MANG with high confidence.
2026-04-30 English
Oxurion - Special report BoD 7-228 (NL)_exe.pdf
Management Reports Classification · 95% confidence The document is a detailed report from the Board of Directors (Raad van Bestuur) of Oxurion, discussing the financial situation of the company as of December 31, 2025. It references statutory financial statements, losses, equity position, and the application of a legal procedure under article 7:228 of the Belgian Companies and Associations Code (Wetboek van Vennootschappen en Verenigingen). The report includes detailed financial data such as assets, liabilities, income, and losses, and discusses measures to safeguard the company's continuity, including financing arrangements and strategic initiatives. The document is titled as a "Bijzonder verslag van de raad van bestuur" (Special report of the Board of Directors) pursuant to a specific legal article, which is a formal management report on the financial condition and proposed measures. It is not an annual report (10-K), audit report, or earnings release, but a special management report required by law when net assets fall below a threshold. The content is substantive and detailed, not a brief announcement or certification. Therefore, the document fits best under Management Reports (MDA), which cover management's detailed explanation of financial results, business trends, and outlook, including special reports on financial distress and proposed measures.
2026-04-30 Dutch
Oxurion_Voting_Form_AGM_2026_exe.pdf
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a detailed voting form for shareholders to vote by letter on the agenda of an upcoming ordinary general meeting (AGM) of Oxurion. It includes agenda items such as acknowledgment of the delay of the AGM, approval of the board's report, approval of the statutory annual accounts for the year ended 31 December 2025, approval of the remuneration report, discharge of directors and auditors for the fiscal year ended 31 December 2025, and granting powers to representatives for filing and publication. The document is clearly related to the preparation and conduct of the AGM, providing shareholders with the means to vote remotely on AGM agenda items. It is not the AGM presentation materials themselves, nor is it the annual report or audit report. It is a proxy or voting form for the AGM. Therefore, the document best fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA), as it is directly related to shareholder voting at the AGM. However, since it is a voting form (ballot) rather than the actual voting results, and given the definitions, the closest category is DVA, which covers official results and voting rights announcements related to shareholder meetings. Confidence is high given the explicit references to voting by letter for the AGM agenda items and the detailed voting instructions.
2026-04-30 Dutch
Oxurion_Convening notice_AGM_2026_exe.pdf
AGM Information Classification · 100% confidence The document is an invitation and agenda for the Ordinary General Meeting of Shareholders (Annual General Meeting) of Oxurion scheduled for June 1, 2026. It includes detailed agenda items such as approval of the annual accounts, remuneration report, discharge of directors and auditors, and procedural details for participation and voting. The text is primarily about convening the AGM and providing shareholders with information on the meeting's agenda and voting procedures. It does not contain the actual annual report, financial statements, or audit reports themselves, but rather references them as items to be discussed or approved at the meeting. The document is lengthy (15,000 characters) but is clearly a meeting notice and agenda, which fits the definition of AGM Information (AGM-R).
2026-04-30 Dutch

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.